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Introduction
What is Retinitis Pigmentosa
(RP)?
Retinitis pigmentosa, also known as RP,
refers to a group of inherited diseases
causing retinal degeneration. Worldwide,
RP affects 1:5,000 people. The retina is a
thin piece of tissue lining the back of the
eye. It converts light into electrical signals
that the brain interprets as vision. People
with RP experience a gradual decline in
their vision, because photoreceptor cells in
the retina degenerate. (Latham, 2017).
Since retinitis pigmentosa begins as rod
degeneration, the patient first notices
increasing difficulty in night vision,
followed by difficulty seeing in the
periphery.

Diagnosis & Testing
Genetic testing. This test looks at a sample of your blood or other tissues to see if
you have certain genes that are associated with a disease. It can also help determine
the likely course or severity of a disease.
Electroretinography. This test measures the electrical activity in the retina, or how
well the retina responds to light. It works much like the EKG, which measures the
activity and health of the heart.
Visual field testing. Retinitis pigmentosa can affect your peripheral (side) vision.
Visual field testing helps measure your side vision and find any blind spots that may
be developing.
Optical coherence tomography. Also known as OCT, this imaging test takes special,
highly detailed pictures of your retina. It can help diagnose RP and find out how it is
affecting your retina. (Campochiaro, 2018).

RP is an inherited disorder that results from harmful changes in any one of more than
50 genes. These genes carry the instructions for making proteins that are needed in
cells within the retina, called photoreceptors. Some of the changes, or mutations,
within genes are so severe that the gene cannot make the required protein, limiting
the cells function. Other mutations produce a protein that is toxic to the cell. Still other
mutations lead to an abnormal protein that doesn’t function properly (Hafler, 2016).
RP is characterized by changes in pigment and arteriolar attenuation, often with some
degree of optic nerve atrophy. Post-mortem examination has shown that the
pigmentation is caused by cells from the pigment epithelium budding off and settling
within the layers of the neural retina. In the late stages of RP a thinning of the retinal
blood vessels is seen, probably resulting from the loss of many retinal cells reducing
the need for blood (Yang, 2018).
A variety of retinal molecular pathway defects have been matched to multiple known
RP gene mutations. Mutations in the rhodopsin gene, which is responsible for the
majority of autosomal-dominantly inherited RP cases, disrupts the rod-opsin protein
essential for translating light into decipherable electrical signals within the
phototransduction cascade of the central nervous system (Yang, 2018).

RP can be inherited in one of three ways:
Autosomal recessive Inheritance
In autosomal recessive inheritance, it takes
two copies of the mutant gene to give rise to
the disorder. An individual with a recessive
gene mutation is known as a carrier. When
two carriers have a child, there is a:
•1 in 4 chance the child will have the disorder
•1 in 2 chance the child will be a carrier
•1 in 4 chance the child will neither have the
disorder nor be a carrier
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Signs & Symptoms

Implications for Care

•

Retinitis Pigmentosa is a genetic disease with no current cure.

•

Earliest sign is night blindness

•

There are treatments out there, however it is only to slow the death rate of rod
and cone cells

•

Finding a cure is still years away, however researchers have already started
human clinical trials

•

Some people develop RP even without a family history

•

Genetic testing is available to those who think they may have or carry the trait.

•

Safety is priority #1 for patients with RP

There is no single treatment, and no cure for retinitis pigmentosa.
Research shows that taking certain vitamins, including vitamin A palmitate, may help
some people with retinitis pigmentosa.

•Loss of side (peripheral) vision

Some patients develop swelling of the retina and may be helped by a certain type of
eye drop.

•Loss of central vision (in
advanced cases)

Cataracts or clouding of the eye’s lens may also develop and surgery to treat this might
be helpful for some patients.
There is also an “artificial retina” called the ARGUS II implant, which may be helpful for
some patients with severe vision loss due to retinitis pigmentosa (Ahuja, 2013)

•Decreased vision at night or in
low light
•Eye fatigue
•Difficulty seeing in dim light

•

•

•
•

Patients should have annual
examinations, including visual
field testing and periodic
(every 5 years) ERG
evaluations (Levinson, 2017)
Low-vision specialists can
provide magnifying devices
and field-expanding lenses
for patients with RP who
have poor central vision.
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Autosomal dominant Inheritance
In this inheritance pattern, it takes just one
copy of the gene with a disorder-causing
mutation to bring about the disorder. When a
parent has a dominant gene mutation, there
is a 1 in 2 chance that any children will inherit
this mutation and the disorder.
X-linked Inheritance
In this form of inheritance, mothers carry the
mutated gene on one of their X
chromosomes and pass it to their sons.
Because females have two X chromosomes,
the effect of a mutation on one X
chromosome is offset by the normal gene on
the other X chromosome. If a mother is a
carrier of an X-linked disorder there is a:
•1 in 2 chance of having a son with
the disorder
•1 in 2 chance of having a daughter who is
a carrier
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Significance of Pathophysiology

Retinitis pigmentosa can be diagnosed and measured by:

Retinitis pigmentosa is a genetic condition
that can be passed down in families. The
type and speed of vision loss from retinitis
pigmentosa varies from person to person.
It depends on their form of the condition

“I chose this topic because of a
family member who is currently
living with retinitis pigmentosa.
Not knowing much about the
disease, I wanted to educate
myself so that I would have a
better understanding of the
subject and be able to be a
resource to him and other family
members. Since it is a genetic
mutation, I want to be informed
in the instance that my husband
or son develop symptoms of the
disease”
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